Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
27.02.26
/
50%
€32.80
Target price
27.02.27
€93.24
Performance (%)
38.32%
Price
18.05.26
€45.45
Summary
This prediction is currently active. With a performance of 38.32% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 27.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % |
| iShares S&P 500 | -2,72 % | -1,75 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.65
20.08.25
20.08.25
€105.76
20.08.26
20.08.26
-21.30%
18.05.26
18.05.26
